Medu Group has acquired Endotech SpA for an undisclosed amount. Endotech SpA, founded in 1995 and based in Como, Italy, is an Italian leading company in the field of medical devices and medical equipment. The acquisition sees Medu Group taking full ownership of Endotech, a firm recognized for its market leadership in the distribution of highly innovative technologies for the treatment of cardiovascular diseases within the Italian market.
Endotech has built a strong reputation as an ideal partner for the distribution of medical devices in Italy. Its history is marked by the successful introduction of products that have become gold standards in cardiovascular care. The company operates with a professional, knowledgeable commercial structure and technical and sales support network that spans the entire national territory. Endotech is committed to offering healthcare clinics the most innovative medical technologies from international companies and startups, aiming to improve patients' quality of life. The company also holds ISO 13485:2016 and 9001:2015 certifications, underscoring its robust operational and quality management systems.
This acquisition is a strategic move for Medu Group, aiming to significantly strengthen its presence and capabilities within the medical device sector, particularly in the specialized area of cardiovascular health. By integrating Endotech's established distribution network, deep market expertise, and portfolio of innovative cardiovascular technologies, Medu Group expects to enhance its market reach and product offerings in Italy. The addition of Endotech's highly professional team and its excellent clinical support capabilities will provide substantial complementary strengths to Medu Group's operations.
The combined entity is poised to deliver a more comprehensive and impactful range of medical solutions to the Italian healthcare market. This integration is expected to foster continued innovation and expand access to advanced medical technologies, ultimately benefiting healthcare providers and patients across the country. The acquisition underscores a commitment to advancing patient care through a broader and more specialized offering in medical devices.